Ipca Laboratories Limited Share Price & Technical Analysis
IPCALAB · ₹1,571 (-1.94%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹1,571
-1.94%
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic th…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
3% return in May, -4% avg return in past 3 year May month.
19% return in 2026, 20% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 4% | 9% | 9% | -4% | 3% | – | – | – | – | – | – | – | 19% |
| 25 | -15% | -3% | 11% | -6% | 2% | -3% | 7% | -7% | -3% | -5% | 14% | -3% | -10% |
| 24 | 1% | 6% | 3% | 8% | -14% | -4% | 15% | 6% | 7% | 6% | -4% | 10% | 41% |
| 23 | 1% | -5% | 0% | -12% | -2% | 5% | 18% | 0% | 7% | 5% | 14% | -2% | 30% |
| 22 | -5% | -6% | 10% | -5% | -10% | -1% | 12% | -10% | 2% | -1% | -4% | -3% | -20% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Uptrend · Uptrend
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹382.87B
P/E ratio
42.01
52W high
₹1,678
52W low
₹1,252
Volume
1,09,281
Beta
0.07
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Ipca Laboratories Limited share price today?
- Ipca Laboratories Limited (IPCALAB) last traded around ₹1,571 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does IPCALAB have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for IPCALAB. Download the app for real-time alerts.
- How can I analyze Ipca Laboratories Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.